17 results
Topical drug formulations, comparison and considerations

#pharmacology #table #medications #comparison #drugs #treatment #pharmacotherapy #dermatology
Topical drug formulations ... considerations #pharmacology ... medications #comparison #drugs ... #treatment #pharmacotherapy ... #dermatology
The World Health Organization's (WHO's) Pain Relief Ladder is a stepwise approach to the management of
approach to the management ... of cancer pain. ... Opioids #Analgesics #Treatment ... #Management #Pharmacotherapy ... #Oncology #PalliativeCare
Managing warfarin INR

Warfarin dosage must be individualized according to the patient's response to the drug, and
response to the drug ... #management #algorithm ... #pharmacology # ... treatment #medications ... #hematology #warfarin
COVID-19 review…here is a list of some of the drugs that are currently being used or
of some of the drugs ... here are the 4 drug ... #Management #Pandemic ... InfectiousDiseases #Pharmacotherapy ... #Pharmacology #
Treatment algorithm for VTE in Malignancy

(A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
incidental DVT or PE in cancer ... thrombosis in cancer ... §Assess drug-drug ... Anticoagulation #Management ... #Hematology #Oncology
Approach to the Rash in a an oncology patient - MINT-C Mnemonic
M - Malignancy: Leukemia cutis,
the Rash in a an oncology ... Gangrenosum, NEH T - Treatment ... : Morbilliform Drug ... differential #diagnosis #cancer ... MINTC #Mnemonic #dermatology
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
algorithm for the treatment ... of cancer-associated ... VTE #Malignancy #Cancer ... Anticoagulation #Management ... #Hematology #Oncology
Summary of meta-analysis of pharmacotherapy trials in BPD
https://www.cochrane.org/CD005652/BEHAV_psychological-therapies-borderline-personality-disorder
Meta-analyses of RCTs were undertaken for the following outcomes:
psychopathology, anger ... Guideline for the Management ... with ‘treatment ... and 5.4 #EBM #Management ... #Pharmacology #
(DOAC interactions) Cancer-treatment specific inducers (↑) and inhibitors (↓)
of cytochrome p450 CYP3A4 and P-glycoprotein.

DOACs are substrates
interactions) Cancer-treatment ... #Chemotherapy #Oncology ... #Hematology #Interactions ... #Table #Pharmacology
Sweet Syndrome

Acute febrile neutrophilic dermatosis (Sweets Syndrome) is a skin condition characterized by fever and inflamed
, breast CA - Hematologic ... cancer such as ... - Drug induced ... Treatment: - Systemic ... #oncology